H. LEE MOFFITT CANCER CENTER & RESEARCH INSTITUTE, INC.;UNIVERSITY OF SOUTH FLORIDA;MODULATION THERAPEUTICS
发明人:
LORI HAZLEHURST,MARK MCLAUGHLIN,RAJESH R. NAIR
申请号：
US14263631
公开号：
US20140322227A1
申请日:
2014.04.28
申请国别(地区):
US
年份:
2014
代理人:
摘要：
The present invention concerns the use of HYD1 peptides to reduce activated T-cell numbers and/or to promote bone preservation in vivo. The present invention concerns methods of treating a bone deficiency and/or an autoimmune disorder, comprising administering an effective amount of a HYD1 peptide. Another aspect of the invention concerns a pharmaceutical composition comprising a HYD1 peptide and another agent for treating a bone deficiency and/or another agent for treating an autoimmune disorder.
